# Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies
Canonical URL: https://biopharmsignal.com/news/ADIL/adial-pharmaceuticals-granted-new-u-s-patent-expanding-coverage-of-its-genetic-based-approach-to-treating-and-diagnosing-alcohol-use-disorder-and-other-drug-dependencies
Ticker: ADIL
Company: Adial Pharmaceuticals
Source: Adial Pharmaceuticals
Published: 2025-02-19 09:00 EST
Original Source URL: https://www.pressviewer.com
## Summary

<div class="b2iNewsItemBodyDiv"><link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="center"> <em>New Patent covers claims which focus on method for identifying genetic markers in patients with alcohol or opioid related disorders</em></p> <p align="center"><em>Pate

## Article Body
New Patent covers claims which focus on method for identifying genetic markers in patients with alcohol or opioid related disorders

Patent expands the identification of potential treatment candidates for AD04 administration based on the patient's unique genetic profile

GLEN ALLEN,...
## Recent Company News
- 2025-06-11 08:00 EST — [Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04](https://biopharmsignal.com/news/ADIL/adial-pharmaceuticals-advances-toward-phase-3-development-for-ad04) — Source: Adial Pharmaceuticals
- 2025-05-15 08:30 EST — [Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update](https://biopharmsignal.com/news/ADIL/adial-pharmaceuticals-reports-first-quarter-2025-financial-results-and-provides-business-update) — Source: Adial Pharmaceuticals
- 2025-05-13 08:30 EST — [Adial Pharmaceuticals Receives Milestone Payment from Adovate Following Initiation of Phase 1 Study](https://biopharmsignal.com/news/ADIL/adial-pharmaceuticals-receives-milestone-payment-from-adovate-following-initiation-of-phase-1-study) — Source: Adial Pharmaceuticals
- 2025-05-08 08:30 EST — [Adial Pharmaceuticals Granted End of Phase 2 Meeting from the U.S. Food and Drug Administration](https://biopharmsignal.com/news/ADIL/adial-pharmaceuticals-granted-end-of-phase-2-meeting-from-the-u-s-food-and-drug-administration) — Source: Adial Pharmaceuticals
- 2025-05-02 11:48 EST — [Adial Pharmaceuticals Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds](https://biopharmsignal.com/news/ADIL/adial-pharmaceuticals-announces-a-warrant-inducement-transaction-for-2-75-million-in-gross-proceeds) — Source: Adial Pharmaceuticals
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)